Biotech

Paladin Labs Announces Proposed Increased Offer to Acquire Afexa Life Sciences for $0.81 per Share

MONTREAL, CANADA: - Increased offer will be made upon cease-trade of Afexa Rights Plans - 14% premium to the Valeant bid - Choice of $0.81 in cash or 0.0217 of a Paladin share per Afexa share - Offer remains for any an ...

Aeolus Pharmaceuticals Files Request for Orphan Drug Designation of AEOL 10150 for Mitigation, and/or Treatment of Delayed Effects of Acute Radiation Exposure of the Lung

MISSION VIEJO, CA: ...

Paladin Labs Announces Intention to Enhance Offer for Afexa Life Sciences

MONTREAL, CANADA: ...

VIRxSYS Issued Third U.S. Patent This Year for Its Spliceosome-Mediated RNA Trans-Splicing (SMaRT(TM)) Program; Breakthrough RNA Therapeutic Platform

GAITHERSBURG, MD: ...

ProMetic Wins New Business With Large Chinese Biotech Company and Secures Initial Bulk Order

LAVAL, QUEBEC: ProMetic further expands their Asian reach through leading Chinese biopharmaceutical companies ProMetic's proven technologies to provide significant economic and competitive advantages ...

MWI Agrees to Acquire Assets of Micro Beef Technologies, Ltd.

BOISE, ID: ...

Cleveland BioLabs Subsidiary Incuron Receives $5 Million Grant From Russian Federation Government Initiative

BUFFALO, NY: ...

Sunshine Heart Raises A$7.4 Million in Two-Tranche Private Placement

SYDNEY, AUSTRALIA and EDEN PRAIRIE, MN: ...

Warnex Launches PRO-DNA(R) Lead, a New Forensic DNA Testing Service

LAVAL, QUEBEC: Warnex collaborates with Sorenson Forensics ...

First China Pharma Adopts SEC Balance Sheet Recommendation

HONG KONG: Company Forecasts Best Ever Q3 Sales Figures ...